What Blood Tests Detect Alcohol Abuse?

Several blood tests can flag alcohol abuse, and they work in fundamentally different ways. Some detect alcohol itself or molecules the body produces only when alcohol is present. Others pick up on the damage alcohol causes to the liver, blood cells, or specific proteins over weeks of heavy drinking. No single test is perfect on its own, which is why clinicians and forensic specialists typically combine markers to build a more reliable picture of someone’s drinking pattern.

Direct Versus Indirect Markers

The distinction between “direct” and “indirect” biomarkers matters because it determines what question a test actually answers. A direct marker is a substance that exists in your blood only because you consumed alcohol. It tells you that ethanol entered the body. An indirect marker is something the body normally produces or regulates but that shifts out of its usual range when heavy drinking disrupts normal metabolism. Indirect markers tell you that something consistent with heavy alcohol use is happening inside the body, but they can also be thrown off by other conditions.

Research on both categories has expanded considerably. A forensic study examining 125 subjects with varied drinking histories found that combining both direct and indirect biomarkers improved the ability to classify chronic alcohol abusers compared with relying on either type alone.¹ Understanding what each test measures, how long it stays positive, and what can cause a misleading result helps make sense of any panel your doctor orders.

Phosphatidylethanol (PEth)

PEth has become one of the most talked-about alcohol biomarkers in both clinical and transplant settings. It is a phospholipid that forms in red blood cell membranes only when ethanol is present, through an enzymatic reaction that swaps a normal building block for ethanol.² Because the body does not make PEth without alcohol, a positive result is highly specific. PEth accumulates with repeated drinking and clears slowly, giving it a detection window of roughly two to four weeks after the last drink.

A systematic review of the literature found that PEth levels generally correlate with how much alcohol someone consumed in the previous two weeks, though the cutoff values laboratories use vary widely. Sensitivity across studies ranged from about 58% to 100%, and specificity from 64% to 100%, depending on which threshold was chosen.³ In a validation study at a liver transplant center, PEth outperformed every traditional biomarker for both sensitivity and specificity. At its lowest detectable level, PEth was 95% sensitive at catching any drinking at all. At a higher cutoff, it was roughly 86% sensitive and 92% specific for heavy drinking.⁴

PEth’s reliability makes it especially valuable in high-stakes situations like organ transplant evaluation. In a study of liver transplant recipients, about a quarter of alcohol-dependent patients who said they were not drinking tested positive on PEth, suggesting the biomarker catches underreporting that self-report questionnaires miss.⁵ Researchers have also noted that while urine ethyl glucuronide is the standard in many transplant guidelines, accumulating data suggest PEth could add significant value and objectivity to that process.⁶

Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS)

EtG and EtS are direct metabolites of ethanol. Your liver produces them as it processes alcohol, and they linger in blood and urine well after alcohol itself has been fully broken down. In blood, both markers peak about four to seven hours after drinking and are found at different concentrations depending on whether you measure whole blood or serum. EtG concentrates more in serum, with a blood-to-serum ratio averaging around 0.58. EtS distributes more evenly, with an average ratio of about 0.81.⁷

The practical upshot is that EtG and EtS are primarily short-window tests. In blood, they are useful for detecting drinking within the past day or so. In urine, the window stretches to roughly 24–72 hours, depending on how much was consumed. This makes them better suited for confirming recent use or verifying abstinence over a few days than for diagnosing a pattern of chronic abuse. They are commonly used in treatment programs and legal settings where frequent monitoring is the goal.

Carbohydrate-Deficient Transferrin (CDT)

CDT is the most established indirect marker. Transferrin is a protein that carries iron in the blood, and it normally has sugar molecules (carbohydrate chains) attached. Sustained heavy drinking interferes with the process that attaches those sugars, so the proportion of transferrin lacking its usual carbohydrate decoration rises. CDT is widely available and particularly useful for identifying recent heavy consumption, especially when combined with other liver-related enzymes.⁸

In terms of diagnostic accuracy, CDT performs well when alcohol has been consumed in the prior week. One study comparing several common markers during abstinence found that CDT had the highest area under the curve of 0.98 for detecting recent alcohol use, outperforming liver enzyme tests like ALT.⁹ CDT typically starts rising after about two weeks of heavy drinking and returns to normal within two to four weeks of abstinence, making it a reasonable window marker for binge-to-chronic patterns.

There are important limitations, though, particularly for women. At specificities above 90%, CDT detected about 79% of male alcohol abusers but only 44% of female abusers. GGT fared similarly poorly in women. Combining both tests boosted detection to 95% for men but only 72% for women.¹⁰ This sex gap is a genuine blind spot in alcohol screening, and clinicians working with women may need to lean more heavily on direct markers like PEth.

Gamma-Glutamyl Transferase (GGT)

GGT is probably the most frequently ordered alcohol-related enzyme, in part because it is cheap and part of routine liver panels. It rises in about three-quarters of people with alcohol dependence who drink more than roughly 40 grams of pure alcohol per day. In people with alcoholic liver disease, GGT can climb to more than ten times the normal upper limit. The catch is that GGT rises for many other reasons: obesity, medications, bile duct problems, and other liver diseases can all push it up.¹¹

GGT also has some demographic blind spots. In people under 30, it tends to be less useful because the age-dependent normal range makes small elevations harder to interpret. Its performance is also limited in women and in binge drinkers who may not drink daily. If someone stops drinking, GGT’s half-life is about two to three weeks, so it takes roughly four to five weeks to drift back to normal. That slow decline makes it useful for monitoring abstinence over time but unreliable for pinpointing a single drinking episode.¹¹

The AST-to-ALT Ratio

The two liver enzymes AST (aspartate aminotransferase) and ALT (alanine aminotransferase) show up on virtually every standard blood panel. Neither one alone is specific for alcohol, but their ratio tells a surprisingly useful story. In alcoholic liver disease, AST tends to be higher than ALT, while in non-alcoholic fatty liver disease the pattern usually reverses. One study found that patients with alcoholic liver disease had a mean AST-to-ALT ratio of 2.6, compared with 0.9 for those with non-alcoholic fatty liver.¹² A ratio of 2 or higher is strongly suggestive of alcohol as the cause.¹³

This ratio is not a standalone diagnostic tool, but when a patient has elevated liver enzymes and the question is “is alcohol responsible?”, the AST-to-ALT ratio is one of the fastest clues available. Doctors often pair it with GGT and the patient’s history to triangulate.

Mean Corpuscular Volume (MCV)

MCV measures the average size of your red blood cells. Chronic heavy drinking can cause red blood cells to become abnormally large, a condition called macrocytosis. The mechanism is not fully settled, but research suggests that acetaldehyde, the toxic breakdown product of alcohol, may modify proteins on red blood cell surfaces and trigger immune responses that disrupt normal cell production.¹⁴

MCV is insensitive on its own. It rises slowly, often requiring months of heavy drinking to cross the abnormal threshold, and it drops slowly too because red blood cells live for about 120 days. Other conditions, including vitamin B12 or folate deficiency, thyroid disease, and certain medications, also cause macrocytosis. Still, when elevated MCV shows up alongside raised GGT and a high AST-to-ALT ratio, the pattern becomes more convincing. One study found MCV had a sensitivity of about 83% and similar specificity for distinguishing alcoholic from non-alcoholic liver disease when used as part of a combined index.¹⁵

Why Multi-Marker Panels Outperform Single Tests

Because every individual marker has gaps, researchers have tried combining routine blood tests into composite scores. One approach, called the Early Detection of Alcohol Consumption (EDAC) test, feeds results from multiple routine lab values into a statistical model. It achieved about 81% sensitivity and 84% specificity, correctly classifying roughly 83% of subjects overall. The top three contributing variables were the ratio of direct to total bilirubin, AST, and albumin.¹⁶

This matters practically because many of these routine tests are already being run during a standard physical. A clinician does not necessarily need to order a specialized PEth test if an algorithmic combination of routine labs can flag risk. That said, the specialized direct markers tend to outperform indirect panels for confirming actual recent consumption. The choice often comes down to context: routine screening in a primary care visit versus definitive monitoring in a transplant program versus forensic documentation for a custody hearing.

Confounders and False Positives

One of the trickiest aspects of indirect alcohol biomarkers is that they are not specific to alcohol. GGT is the prime example. A case series documented patients with a history of alcohol misuse whose GGT stayed elevated during abstinence. The persistently raised GGT was incorrectly attributed to continued drinking, when the actual cause was obesity-related fatty liver.¹⁷ Given that obesity is common, this scenario plays out more often than people realize. Medications, viral hepatitis, diabetes, and iron-overload conditions can also push GGT, CDT, or liver enzymes in directions that mimic alcohol abuse.

Direct biomarkers like PEth are much harder to fool. Because PEth forms only through a reaction that requires ethanol, false positives from unrelated conditions are rare. EtG is also highly specific, though it can turn up positive from incidental ethanol exposure (hand sanitizer, mouthwash, or fermented foods) in very sensitive urine assays. Blood EtG testing is less prone to this problem because the concentrations from incidental exposure are typically too low to register.

Why Sex and Body Composition Matter

Alcohol biomarkers do not perform equally across all groups. Women tend to reach higher blood alcohol concentrations than men from the same amount of alcohol, partly because women have less first-pass metabolism in the stomach and a smaller volume of distribution. Gastric emptying of alcohol is also slower in women, and hepatic oxidation runs somewhat higher.¹⁸ These pharmacokinetic differences mean that the same drinking pattern can produce different biomarker levels depending on the patient’s sex, body weight, and metabolic profile.

As noted earlier, CDT’s sensitivity drops substantially in women. The reasons are not entirely clear but may relate to hormonal influences on transferrin glycosylation. For female patients, direct markers or multi-marker panels provide a more reliable picture than CDT alone.

Forensic and Legal Uses

Alcohol biomarkers are not just clinical tools. They are used in legal proceedings, from child custody disputes to driver’s license reinstatement hearings. In these settings, a biomarker needs to answer two questions: was this person drinking, and were they drinking heavily? A German review noted that biomarkers of alcohol consumption are important in forensic contexts, including documenting abstinence after a license has been temporarily confiscated.¹⁹

The legal weight of a biomarker result depends on how well-established the test is and how clearly its cutoffs have been validated. CDT and GGT have decades of use in courtrooms, but their susceptibility to confounders can be challenged by defense experts. PEth is newer to the legal arena but harder to dispute because of its biological specificity. Forensic programs increasingly use a combination of hair analysis (which can capture a months-long drinking history) with blood-based markers for corroboration.

How Quickly Alcohol Clears and Why That Shapes Which Test You Need

The body eliminates ethanol itself at a fairly fixed rate. Classic pharmacokinetic data puts the maximum elimination capacity at about 8.5 grams per hour for an average-sized person, which translates to a blood alcohol disappearance rate of roughly 230 mg/L per hour at peak metabolic capacity.²⁰ What this means in practical terms is that ethanol itself vanishes from the blood within hours of the last drink. If you are looking for evidence of drinking that happened yesterday, you need a metabolite or a downstream effect, not ethanol.

This is exactly why the various biomarkers exist on a time spectrum. EtG and EtS cover the past one to three days. PEth covers the past two to four weeks. CDT covers roughly the past two to four weeks as well, though with less specificity. GGT takes four to five weeks to normalize. MCV is the slowest of all, reflecting months of cumulative exposure. Choosing the right test depends on what time window matters for your question.

Sample Handling and Stability

A detail that rarely comes up in patient-facing conversations but matters enormously in forensic and research settings is what happens to the blood sample between collection and analysis. Most studies find that blood alcohol concentrations decrease after collection depending on storage time, temperature, and how much sodium fluoride preservative is added. Stored in a refrigerator for up to a few weeks, the changes are not significant. After a year at refrigerator temperature, levels can drop by a small but measurable amount.²¹ The loss is driven by oxidation, particularly by oxyhemoglobin in red blood cells, which is why ethanol is more stable in plasma or serum than in whole blood.²² For urine samples, patients with diabetes-related glycosuria or urinary tract infections may see post-collection ethanol production if preservatives are not added.

Emerging Markers on the Horizon

The next generation of alcohol biomarkers may not involve enzymes or metabolites at all. Researchers are investigating circulating microRNAs, tiny snippets of genetic material that float in the blood and change in response to lifestyle factors including alcohol consumption.²³ A case-control study found that two specific microRNAs, miRNA-92b and miRNA-382-5p, showed statistically significant differences between people with alcohol dependence and controls, suggesting they could serve as diagnostic biomarkers.²⁴ These findings are early-stage, and microRNA panels are not yet available in routine clinical labs. But they represent a potentially powerful addition because they could capture biological changes caused by heavy drinking that current tests miss, including organ-specific damage signatures that go beyond what liver enzymes can show.